OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
COL.CS56

Colorado Ste des Ets SA

Commodity ChemicalsVerified

The company's capital structure and liquidity position remain unclear due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of data prevents a comprehensive assessment of its liquidity risk. Profitability and returns are not quantifiable at this time, as the valuation snapshot does not provide the necessary metrics for comparison against industry standards or cohort medians. The company's financial performance in terms of return on invested capital (ROIC) and margins remains undetermined. The company's segments and geographic exposure are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. There is no information on the distribution of revenue across different business segments or regions. The growth trajectory of the company is not clearly defined, as the outlook for the current and next fiscal years lacks numeric deltas and historical revenue data for analysis. The absence of detailed growth projections and past performance metrics hinders the ability to evaluate its future potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in the source documents. The dilution potential is currently low, and no adjustments have been applied to the valuation metrics. However, the absence of detailed risk assessments limits the understanding of other potential risks. Recent events, such as filings and transcripts, are not available in the provided data, which prevents the inclusion of any recent developments that might impact the company's operations or financial status.

30-day price · COL.CS-0.94 (-1.1%)
Low$78.51High$84.46Close$81.00As of11 May, 00:00 UTC
Profile
CompanyColorado Ste des Ets SA
TickerCOL.CS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Colorado Ste des Ets SA is a chemical company that produces commodity chemicals, primarily generating revenue through the sale of chemical products in the Basic Materials sector.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

The company's capital structure and liquidity position remain unclear due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of data prevents a comprehensive assessment of its liquidity risk. Profitability and returns are not quantifiable at this time, as the valuation snapshot does not provide the necessary metrics for comparison against industry standards or cohort medians. The company's financial performance in terms of return on invested capital (ROIC) and margins remains undetermined. The company's segments and geographic exposure are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. There is no information on the distribution of revenue across different business segments or regions. The growth trajectory of the company is not clearly defined, as the outlook for the current and next fiscal years lacks numeric deltas and historical revenue data for analysis. The absence of detailed growth projections and past performance metrics hinders the ability to evaluate its future potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in the source documents. The dilution potential is currently low, and no adjustments have been applied to the valuation metrics. However, the absence of detailed risk assessments limits the understanding of other potential risks. Recent events, such as filings and transcripts, are not available in the provided data, which prevents the inclusion of any recent developments that might impact the company's operations or financial status.
Key takeaways
  • The company's liquidity risk cannot be assessed due to missing balance-sheet data.
  • Profitability and returns metrics are not available for comparison with industry standards.
  • There is no information on the company's segments or geographic exposure.
  • Growth trajectory and future performance projections are not clearly defined.
  • The risk assessment is limited, with liquidity risk being the primary concern.
  • # RATIONALES
  • margin_outlook_rationale: The margin outlook is indeterminate due to the lack of detailed financial data and historical performance metrics.
  • rd_outlook_rationale: Research and development outlook is not available as there is no information on the company's R&D activities or investments.
Financial snapshot
PeriodHA-latest
CurrencyMAD
Revenue$129.6M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$574.1M$54.9M$33.2M$55.9M
FY-3$609.9M$57.2M$35.4M$36.5M
FY-2$611.4M$62.0M$38.6M$46.2M
FY-1$605.0M$76.7M$45.3M$65.8M
FY0$624.0M$95.9M$65.5M$78.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$648.4M$317.4M$6.3M
FY-3$542.0M$320.1M$5.5M
FY-2$546.5M$326.5M$6.3M
FY-1$569.5M$335.7M$9.4M
FY0$583.4M$359.3M$5.7M
PeriodOCFCapExFCFSBC
FY-4$46.1M-$7.0M$55.9M
FY-3$51.8M-$16.3M$36.5M
FY-2$56.2M-$12.7M$46.2M
FY-1$51.6M-$7.5M$65.8M
FY0$44.6M-$11.5M$78.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$129.6M
FQ-6
FQ-5$184.0M
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricCOL.CSActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Observations
IR observations
Last actual EPS2.27 MAD
Last actual revenue524,556,000 MAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:03 UTC#daaf2c28
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 16:31 UTCJob: 3e834d53